Biotech grants in Poland

Closed

Funds €5M lump-sum projects that build sensor and lab-based methods to map, test and protect Europe's groundwater ecosystems.

Closed

Funds two €4M projects for European consortia building bio-based products and studying whether people will actually adopt them.

Closed

Funds research consortia developing the pre-normative science behind future standards for bio-based chemicals, polymers and other bio-based products.

Closed

Funds one €20M industrial project that scales biotechnology into sustainable biorefineries and market-ready bio-based products.

Closed

Funds two €7M projects that make durable products from renewable feedstocks and give cross-linked plastics viable recycling, reuse or upcycling routes.

Closed

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.

Closed

Funds two €5M projects turning marine organisms — algae, fungi, invertebrates — into safer bio-based replacements for adhesives, coatings and chemicals.

Closed

Funds two €7M projects that turn farm, forestry, aquatic and urban bio-waste into market-ready chemicals, materials and ingredients.

Closed

Funds one €20M industrial project making safe bio-based fertilisers or crop-protection products that work in real fields.

Closed

Funds consortia to cut cost, solvent use, energy and water in biorefineries, tested across at least three industrial or demo-scale use cases.

Closed

Funds two €7M projects turning bark, sawdust and other woody residues into validated bio-based chemicals or materials for sustainable end products.

Closed

Funds two €3.25M projects that turn alternative bio-feedstocks into safe, circular polymers tested across at least two markets.

Closed

Funds two €3.25M projects that turn sustainable biomass or bio-based textile waste into high-performing, circular fibres.

Closed

Funds consortia developing biotech and nature-based decontamination methods for war-damaged land, water and air, proven on real sites in Ukraine.

Closed

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Closed

Funds research consortia, including businesses and startups, that study microbiomes across plants, humans and environments to unlock new food-system applications.

Closed

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds one consortium to run a microbiome research one-stop-shop and coordination hub for EU policymakers and regulators.

Closed

Funds R&D that turns existing food-safety science — molecular methods, genomics, photonics — into deployable tools against food fraud and safety risks.

Closed

Funds for-profit deep-tech companies from any NATO member nation that are developing dual-use solutions to critical defence and security challenges, through competitive annual and dynamic challenge calls.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Closed

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Funds companies and researchers scaling up precision-fermentation microorganisms that turn captured CO2 into food nutrients.

Closed

Funds AU-EU research consortia developing locally-produced therapeutic and supplementary foods for child malnutrition in Africa.